Announced Thu, 9 Jul · 11:17 IST
Non-promoter Snehjeev Ventures crosses 9% stake in Amerise Biosciences via open market
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.0%1-day move
₹0.80
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+5.0+10.0+15.0+18.8+16.3+10.0————
Up moveDown movePending
AI summary
Snehjeev Ventures Pvt Ltd along with PACs (Lunkad family members) acquired 38,574 equity shares (0.06%) of Amerise Biosciences through the open market on 6 July 2026. Holding rose from 8.98 percent (59.33 lakh shares) to 9.04 percent (59.72 lakh shares). The acquirer is not part of the promoter or promoter group. Total share capital is 66.06 lakh equity shares of Rs 10 each. Disclosure filed under SEBI SAST Regulation 29(2).
Likely market impact
Non-promoter creeping buy approaching 10 percent threshold. Further acquisitions beyond 10 percent would trigger additional SEBI disclosures and takeover code implications.